iBio EV 2011-2026 | IBIO

EV Jährlich iBio

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
60.3 M	747 K	21.7 M	35.4 M	-39 M	276 M	36.8 M	31.2 M	46.6 M	69.7 M	38.2 M	21.4 M	24.6 M	44.6 M	87.6 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
276 M	-39 M	50.4 M

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
Immatics N.V. IMTX	503 M	$ 9.4	-1.16 %	$ 591 M	Germany
Incyte Corporation INCY	18.2 B	$ 90.47	0.02 %	$ 17.7 B	USA
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Aileron Therapeutics ALRN	33.1 M	-	10.36 %	$ 9.8 M	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	849 M	$ 215.49	-1.18 %	$ 5 B	Danmark
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	1.92 B	$ 19.43	1.04 %	$ 908 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
CytomX Therapeutics CTMX	971 M	$ 4.19	-5.95 %	$ 578 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
CollPlant Biotechnologies Ltd. CLGN	169 M	$ 0.72	18.96 %	$ 8.25 M	Israel
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Exelixis EXEL	11.9 B	$ 41.39	-0.05 %	$ 11.2 B	USA
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	1.11 B	$ 1.35	-3.57 %	$ 344 M	Britain
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
ChemoCentryx CCXI	91.4 M	-	-	$ 3.74 B	USA
Aytu BioScience AYTU	-15.2 M	$ 2.59	-1.52 %	$ 16.3 M	USA
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
Bellerophon Therapeutics BLPH	77.1 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	847 M	$ 4.29	-3.05 %	$ 822 M	Canada
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Ionis Pharmaceuticals IONS	15.6 B	$ 69.54	-1.77 %	$ 11.1 B	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	515 K	-	-5.38 %	$ 6.06 M	USA
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA
Calithera Biosciences CALA	916 M	-	-10.95 %	$ 876 K	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
Cara Therapeutics CARA	71.1 M	-	-3.03 %	$ 260 M	USA
Harmony Biosciences Holdings HRMY	1.26 B	$ 27.01	-2.14 %	$ 1.55 B	USA
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA